The blood plasma IgGs of patients who recovered from COVID-19 (group 1) had the highest catalase activity; the median value of the apparent kcat for this group was statistically 1.8 times higher than that for the IgGs of the healthy donors (group 4). This evidence concerns the gene CAT and COVID-19.